The Importance of Supply Security
The COVID-19 pandemic emphasized the need for supply chain security. Companies need contingency plans, agility, and collaboration with suppliers to ensure continuity of operations and mitigate risks.
Key Learnings/Outcomes:
-
Increased sensitivity over origins of Active Pharmaceutical Ingredients (API)
-
Providing transparency over sourcing of Key Starting Materials (KSM) - origins, gluten/lactose/dye free
-
Heightened transparency over adequate supply of API and safety stock.
-
Shelf-life of product
-
Supply Chain Consistency/readiness
-
Serialization readiness
-
Customers increasing interest in diversifying their supply risk with high volume categories (e.g. women’s health – thyroid) to minimize service disruptions with incumbent suppliers
-
Opportunities for nearshoring - bringing production, manufacturing capabilities closer to home (i.e., US market)
Provell Pharmaceuticals continues to meet and exceed these expectations of our customers and patients.
Provell is committed to:
-
Source products with API/KSM from countries within Europe
-
Maintain at minimum an adequate supply of product to meet existing demand and allocate additional stock to cover for potential supply disruptions (‘levo-insurance’)
-
Utilize high quality standards and control in the manufacturing and distribution of our products throughout the United States.
Provell Pharmaceuticals remains committed to full compliance with all Drug Supply Chain Security Act (DSCSA) requirements since 2018.
Since product approval, all of their products are serialized to ensure complete traceability down to the smallest dispensed unit.
Learn how Provell is providing the United States the leading dispensed brand of levothyroxine worldwide that is priced in-line with generics to mitigate supply chain risk.
